Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
---|
04/30/2002 | US6380221 Ortho-anthranilamide derivatives as anti-coagulants |
04/30/2002 | US6380220 Therapy of neurodegenerative diseases and neuronal injuries which are casued by ischemia, trauma or massive hemorrhages |
04/30/2002 | US6380218 For therapy of respiratory, allergic, and inflammatory disorders comprising asthma, chronic obstructive pulmonary disease, acute respiratory disease syndrome, pulmonary hypersensitivity, and allergic rhinitis in a mammal |
04/30/2002 | US6380215 For prevention and/or treatment of diseases caused by thrombus formation such as arterial thrombosis, arterial sclerosis, ischemic heart diseases |
04/30/2002 | US6380210 Heteroaryl fused aminoalkyl-imidazole derivatives: selective modulators of GABAa receptors |
04/30/2002 | US6380204 Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor antagonist activity |
04/30/2002 | US6380201 Methods of treating or ameliorating the symptoms of common cold or allergic rhinitis with serotonin 5-HT1F agonists |
04/30/2002 | US6380184 For increased production of wool, milk, and meat by treating animals with therapeutically effective amount of compound |
04/30/2002 | US6380134 N-pyridyl herbicide compounds |
04/30/2002 | US6379882 Exposing a primary culture of retinal ganglion cells to an oxygen/glucose deprivation challenge with and without a test compound; after an incubation period, measure the percentage of apoptotic cells |
04/30/2002 | US6379655 For protection of human skin and/or hair against the damaging effects of ultraviolet irradiation |
04/30/2002 | CA2246994C Novel substituted n-methyl-n-(4-(4-(1h-benzimidazol-2-yl)¬1,4|diazepan-1-yl)-2-(aryl)butyl)benzamides useful for the treatment of allergic diseases |
04/30/2002 | CA2241827C Novel substituted 4-(1h-benzimidazol-2-yl)¬1,4|diazepanes useful for the treatment of allergic diseases |
04/30/2002 | CA2131761C Crystals of pyridonecarboxylic acid derivative |
04/25/2002 | WO2002033026A1 Blends of quinone alkide and nitroxyl compounds as polymerization inhibitors |
04/25/2002 | WO2002032900A2 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
04/25/2002 | WO2002032897A1 Alpha-aryl ethanolamines and their use as beta-3 adrenergic receptor agonists |
04/25/2002 | WO2002032894A1 Substituted imidazoles useful in the treatment of inflammatory diseases |
04/25/2002 | WO2002032893A2 Piperidine compounds as anti-allergic |
04/25/2002 | WO2002032880A1 New derivatives of cyano-aryl (or cyanoheteroaryl)-carbonyl-piperazinyl-pyrimidines, their preparation and application as medication |
04/25/2002 | WO2002032879A1 Dihydropyrimidine derivatives as cysteine protease inhibitors |
04/25/2002 | WO2002032874A2 Substituted heterocyclic compounds for treating multidrug resistance |
04/25/2002 | WO2002032872A1 Nitrogenous aromatic ring compounds |
04/25/2002 | WO2002032871A2 Compounds and methods for treating multidrug resistance |
04/25/2002 | WO2002032869A2 Substituted heterocyclic compounds for treating multidrug resistance |
04/25/2002 | WO2002032868A2 2-substituted heterocyclic compounds and their use in treating multidrug resistance |
04/25/2002 | WO2002032864A1 Pharmaceutically active sulfanilide derivatives |
04/25/2002 | WO2002032863A1 2-, 3-, 4-, or 5-substituted-n1-(benzensulfonyl)indoles and their use in therapy |
04/25/2002 | WO2002032861A2 Orally active salts with tyrosine kinase activity |
04/25/2002 | WO2002032422A2 Ep4 receptor inhibitors to treat rheumatoid arthritis |
04/25/2002 | WO2002010137A3 Indazole derivatives as JNK inhibitors |
04/25/2002 | WO2001058891A3 Piperazine and piperidine derivatives for treatment or prevention of neuronal damage |
04/25/2002 | WO2001056552A3 Farnesyl protein transferase inhibitors for treating breast cancer |
04/25/2002 | WO2001047913A3 Substituted n-benzyl-indol-3-yl glyoxylic acid derivatives having an anti-tumoral effect |
04/25/2002 | WO2001045687A3 Use of bioactive metabolites of gepirone for the treatment of psychological disorders |
04/25/2002 | WO2001002369A3 Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use |
04/25/2002 | US20020049329 Novel human NK3 receptor-selective antagonist compounds, method for obtaining them and pharmaceutical compositions containing them |
04/25/2002 | US20020049328 Such as (R)-1-Cyclopropyl-8-difluoromethoxy-7-(1-methyl-2,3-dihydro-1H-5-isoindolyl)-4-oxo-1,4-dihydro-3-quinolinecarboxyl ic acid methanesulfonate; chemical intermediates; bactericides; catalysis |
04/25/2002 | US20020049327 Such as 7-(3-chlorophenyl)-9-((4-chlorophenyl)-1H-imidazol-1-ylmethyl)-2,3-dihydro -1H,5H-benzo(ij)quinolizin-5-one; for forming oncogenes for signalling transformation of tumor cells |
04/25/2002 | US20020049323 Anxiolytic agents |
04/25/2002 | US20020049322 Quinoline and quinazoline compounds useful in therapy |
04/25/2002 | US20020049243 Pyrrolidine derivatives |
04/25/2002 | US20020049235 Pyridylpyrrole compounds useful as interleukin-and tnf antagonists |
04/25/2002 | US20020049231 S(-)-3-aminothalidomide; treating wide variety of diseases including diabetic retinopathy |
04/25/2002 | US20020049222 Cyclopentyl modulators of chemokine receptor activity |
04/25/2002 | US20020049220 Substituted azoles |
04/25/2002 | US20020049212 Benzimidazole compounds and salts containing piperidine ring are useful in treatment or prevention or medical conditions selected from pain, and inflammatoy diseases; analgesics |
04/25/2002 | US20020049211 Combination treatment for depression and anxiety |
04/25/2002 | US20020049210 Heteroaryl amines as novel acetylcholinesterase inhibitors |
04/25/2002 | US20020049209 Dopamine D4 ligands for the treatment of novelty-seeking disorders |
04/25/2002 | US20020049199 N-linked carbamates and ureas of heterocyclic thioesters |
04/25/2002 | US20020049195 Urea compounds that are muscarinic receptor antagonists and agonists, administering to the mammal the urea compound to treat urinary incontinence, chronic pulmonary obstructive disease, asthma, hyper salivation, blurred vision etc. |
04/25/2002 | US20020049194 A benzoazepin or benzodiazepin derivatives, shows excellent anti-vasopressin activity, vasopressin agonistic activity and oxytocin antagonistic activity, and are useful as antagonist |
04/25/2002 | US20020049193 Inhibitors of the enzyme activity associated with immunophilin proteins, particularly peptidyl-prolyl isomerase, or rotamase, enzyme activity. |
04/25/2002 | US20020049192 6-hydroxy-7-Piperidine-, azetidine- or pyrrolidine-substituted |
04/25/2002 | US20020049148 Bleach catalyst and composition and method for bleaching a substrate |
04/25/2002 | US20020049141 Method of combating undesired plant growth on cereals |
04/25/2002 | US20020049135 Catalysts containing per-ortho aryl substituted aryl or heteroaryl substituted nitrogen donors |
04/25/2002 | DE10051321A1 New 2-(4-amino-piperidin-1-yl)-2-aryl-N-(phenylalkyl)-acetamides, are potent neurokinin antagonists, useful e.g. for treating allergic, inflammatory or central nervous system diseases |
04/25/2002 | DE10050492A1 New butenolide or pentenolide amide derivatives, useful as kinase inhibitors for treating inflammatory and autoimmune diseases, e.g. rheumatoid arthritis, asthma, Alzheimer's disease or osteoarthritis |
04/25/2002 | DE10050490A1 New butenolide or pentenolide amide derivatives, useful as kinase inhibitors for treating inflammatory and autoimmune diseases, e.g. rheumatoid arthritis, asthma, Alzheimer's disease or osteoarthritis |
04/25/2002 | CA2426487A1 Ep4 receptor inhibitors to treat rheumatoid arthritis |
04/25/2002 | CA2426337A1 Substituted imidazoles useful in the treatment of inflammatory diseases |
04/25/2002 | CA2426271A1 Dihydropyrimidine derivatives as cysteine protease inhibitors |
04/25/2002 | CA2426097A1 New derivatives of cyano-aryl (or cyanoheteroaryl)-carbonyl-piperazinyl-pyrimidines, their preparation and application as medication |
04/25/2002 | CA2424689A1 Orally active salts with tyrosine kinase activity |
04/25/2002 | CA2423933A1 Pharmaceutically active sulfanilide derivatives |
04/25/2002 | CA2423792A1 Alpha-aryl ethanolamines and their use as beta-3 adrenergic receptor agonists |
04/25/2002 | CA2422717A1 2-, 3-, 4-, or 5-substituted-n1-(benzensulfonyl)indoles and their use in therapy |
04/25/2002 | CA2422655A1 Blends of quinone alkide and nitroxyl compounds as polymerization inhibitors |
04/24/2002 | EP1199306A1 Biarylurea derivatives |
04/24/2002 | EP1199070A2 Use of PDE V inhibitors for improved fecundity in mammals |
04/24/2002 | EP1198456A2 Potassium channel openers |
04/24/2002 | EP1198234A2 Bicyclic aromatic compounds for treating drug addiction |
04/24/2002 | EP1180366A9 Neuronal death inhibitors |
04/24/2002 | EP0782568B1 Aromatic ethers derived from indols such as 5ht1-like ligands |
04/24/2002 | EP0714299B1 Benzoxazinone and benzopyrimidinone piperidinyl tocolytic oxytocin receptor antagonists |
04/24/2002 | CN1346355A Novel inhibitors of farnesyl-protein transferase |
04/24/2002 | CN1346354A Substituted benzoylpyrazoles as herbicides |
04/24/2002 | CN1346353A Farnesy transferase inhibitors having a pyrrole structure and process for preparation thereof |
04/24/2002 | CN1346350A Compound which inhibiti leukocyte adhesion mediated by VLA-4 |
04/24/2002 | CN1346348A Amide compounds and medicinal use thereof |
04/24/2002 | CN1346347A Cyclic amine derivatives and uses thereof |
04/24/2002 | CN1346282A Use of a cyclooxygenase-2 inhibitor and one or more antineoplastic agents as combination therapy method in treating neoplasia |
04/24/2002 | CN1346271A Quinazoline derivatives as angiogenesis inhibitors |
04/24/2002 | CN1345724A Indolylpiperidine compound and preparation process and use thereof |
04/24/2002 | CN1083439C 2-amino-4-bicyclomino-1,3,5-triazines as herbicides and plant growth regulators |
04/24/2002 | CN1083437C 2-[1',2',4'-triazol-3'-yloxymethylenel anilides,] their preparation and use |
04/24/2002 | CN1083433C Herbicidal heterocyclic-substituted pyridines, its preparation and herbicidal composition and use |
04/24/2002 | CN1083432C Process for preparing amine compound and its salt |
04/24/2002 | CN1083431C Novel heterocyclic compounds |
04/23/2002 | US6376672 Restenosis; vision defects; cardiovascular disorders; kidney dieases |
04/23/2002 | US6376670 Bactericide for grampositive bacteria |
04/23/2002 | US6376668 Reacting pyridinecarbonitrile compound with potassium hydroxide in butanol; hydrolysis |
04/23/2002 | US6376667 Cyclization in presenc eof base |
04/23/2002 | US6376665 Antiarthritic agents, antiinflammatory agents |
04/23/2002 | US6376656 Disazo dyes, triazine dyes |
04/23/2002 | US6376584 Hydroxy-substituted N-alkoxy hindered amines and compositions stabilized therewith |
04/23/2002 | US6376548 Enhanced propertied pesticides |
04/23/2002 | US6376527 Pyrazole derivatives-p38 map kinase inhibitors |